Blog

$Drew Moghanaki: Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT)$

Photo taken from Drew Moghanaki/X

Dec 30, 2023, 17:33

Drew Moghanaki: Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT)

Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on X/Twitter:

“Roswell Park’s 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT) is reported (n=263). Local failures include post-treatment scars that grew more than 20% and had FDG-avidity as bright as pre-treatment. Once again, the treatment site control rates mirror almost all multi-fraction lung SBRT studies.”

$Drew Moghanaki: Roswell Park's 13-year experience with single-fraction lung Stereotactic body radiation therapy (SBRT) 1$

Read further.
Source: Drew Moghanaki/X

cancer Drew Moghanaki FDG-avidity Lung cancer OncoDaily Oncology Roswell Park Stereotactic body radiation therapy (SBRT) UCLA Health Jonsson Cancer Center

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer